Skip to Main Content

Paper Details

Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases.
Int J Cancer
3
2022
BRAF, Colorectal Cancer, CpG, CpG island, CpG island methylator phenotype, Diabetes, Diabetes mellitus, KRAS, KRAS mutations, cancer, colorectal cancer, colorectal tumor, diabetes, tumor, tumor subtypes
Author NameAffiliation
Andrew T ChanMassachusetts General Hospital and Harvard Medical School
Andrew T ChanBrigham and Women's Hospital and Harvard Medical School
Andrew T ChanClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School
Andrew T ChanBroad Institute of MIT and Harvard
Andrew T ChanHarvard T.H. Chan School of Public Health, Harvard University
Andrew T ChanHarvard T.H. Chan School of Public Health, Harvard University
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH)
David A DrewClinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School
Steven GallingerLunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Graham G Giles
Graham G GilesSchool of Clinical Sciences at Monash Health, Monash University
Graham G GilesThe University of Melbourne
Wei SunFred Hutchinson Cancer Research Center
Stephen N ThibodeauMayo Clinic
Ulrike PetersFred Hutchinson Cancer Research Center
Ulrike PetersUniversity of Washington
  • 1 - 17

Datasets

Release 1.2